Acinar cell carcinoma of the pancreas exhibiting a moderate focal CPA1 positivity. (CPA1 immunohistochemistry)
Acinar cell carcinoma of the pancreas exhibiting a moderate focal CPA1 positivity. (CPA1 immunohistochemistry)
Acinar cell carcinoma of the pancreas showing strong CPA1 immunostaining in all tumor cells. (CPA1 immunohistochemistry)
Acinar cell carcinoma of the pancreas showing strong CPA1 immunostaining in all tumor cells. (CPA1 immunohistochemistry)
Complete absence of CPA1 immunostaining in a ductal adenocarcinoma of the pancreas. (CPA1 immunohistochemistry)
Complete absence of CPA1 immunostaining in a ductal adenocarcinoma of the pancreas. (CPA1 immunohistochemistry)
Complete absence of CPA1 immunostaining in a neuroendocrine carcinoma of the pancreas. (CPA1 immunohistochemistry)
Complete absence of CPA1 immunostaining in a neuroendocrine carcinoma of the pancreas. (CPA1 immunohistochemistry)
Ductal adenocarcinoma of the pancreas lacking CPA1 immunostaining. (CPA1 immunohistochemistry)
Ductal adenocarcinoma of the pancreas lacking CPA1 immunostaining. (CPA1 immunohistochemistry)
Moderate focal CPA1 immunostaining involving about 70% of tumor cells of a pancreatic acinar cell carcinoma. (CPA1 immunohistochemistry)
Moderate focal CPA1 immunostaining involving about 70% of tumor cells of a pancreatic acinar cell carcinoma. (CPA1 immunohistochemistry)
Neuroendocrine tumor of the pancreas without CPA1 immunostaining. (CPA1 immunohistochemistry)
Neuroendocrine tumor of the pancreas without CPA1 immunostaining. (CPA1 immunohistochemistry)
Strong CPA1 immunostaining in a pancreatic acinar cell carcinoma. (CPA1 immunohistochemistry)
Strong CPA1 immunostaining in a pancreatic acinar cell carcinoma. (CPA1 immunohistochemistry)